BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rigopoulou EI, Bogdanos DP. Role of autoantibodies in the clinical management of primary biliary cholangitis. World J Gastroenterol 2023; 29(12): 1795-1810 [PMID: 37032725 DOI: 10.3748/wjg.v29.i12.1795]
URL: https://www.wjgnet.com/1007-9327/full/v29/i12/1795.htm
Number Citing Articles
1
Lin Han, Huan Xie, Xue-Mei Ma, Xiao-Long Lu, Jun Zhao, Qing-Sheng Liang, Zheng-Sheng Zou, Jing-Feng Bi, Bo Jin, Ying Sun. Risk factors for esophagogastric variceal-related poor outcomes in primary biliary cholangitis: A prospective cohort studyiLIVER 2024; 3(1): 100081 doi: 10.1016/j.iliver.2024.100081
2
Min Yang, Chao Hu, Jun Huang, Ying Fu, Qi Zhang, Yulan Cheng, Jie Lu, Guiling Li, Jun Zhang. Diagnostic value of anti-hexokinase 1 and anti-kelch-like 12 antibodies in primary biliary cholangitis patientsJournal of Laboratory Medicine 2024; 48(3): 129 doi: 10.1515/labmed-2023-0127
3
Di Ma, Xinglou Liu, Guo Ai, Wen Pan, Lingling Liu, Yuan Huang, Yi Liao, Yuanyuan Lu, Zhan Zhang, Hua Zhou, Zhihua Huang, Xingjie Hao, Sainan Shu, Feng Fang. The etiology and differential diagnosis of “autoimmune hepatitis-like liver disease” in children: a single-center retrospective studyFrontiers in Pediatrics 2024; 12 doi: 10.3389/fped.2024.1377333
4
Silja Steinmann, Christoph Schramm. Primär biliäre Cholangitis – Response-Kriterien der Erstlinientherapie und Perspektiven der ZweitlinientherapieDie Innere Medizin 2024; 65(4): 340 doi: 10.1007/s00108-024-01674-7
5
Francesco Martini, Daniele Balducci, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, Antonio Benedetti, Marco Marzioni, Luca Maroni. Risk Stratification in Primary Biliary CholangitisJournal of Clinical Medicine 2023; 12(17): 5713 doi: 10.3390/jcm12175713